Equity
Dr. SAXENA V.K. has made a profit without a break since 2019.
Dr. SAXENA V.K. has made a profit without a break since 2019.
The accounts state no turnover.
Dr. SAXENA V.K. pays its suppliers 33 days later than in 2023.
Short-term debts rose from €3,992 to €12,252.
2025 accounts not filed: deadline was 31-07-2026.
Higher solvency than 93% of companies in human health. The sector median is 67.4%, over 19,779 companies.
In July 2024, 31,389 companies had the same profile as Dr. SAXENA V.K. has now. Each dot stands for 79 companies, two years later.
Another 0.1% stopped without a precise date, possibly only after those two years.
The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 31,389 companies, not a prediction for Dr. SAXENA V.K.. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
| Company | ||||
|---|---|---|---|---|
| Dr. SAXENA V.K. Edegem | €333,545 | €100,719 | 96.3% | - |
| Dokter R. Alliet Lichtervelde | €315,353 | €99,530 | 97.2% | - |
| NATALIX Le Roeulx | €339,005 | €109,324 | 66.3% | - |
| HEPATOGASTRO Gerpinnes | €313,553 | €94,398 | 84.7% | - |
| DOKTER J. ROOS Turnhout | €384,849 | €102,894 | 80.6% | - |
| DR. S. WYNANTS Hove | €357,170 | €103,366 | 94.8% | - |
| DR BROECKX WALTER, DERMATOLOGIE Mortsel | €305,945 | €85,713 | 57.8% | - |
These companies have the same main activity as Dr. SAXENA V.K.: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €306,000 and €385,000, founded between 1996 and 2002.
Dr. SAXENA V.K. files the micro format. That format states no turnover. The gross margin rose from -€16,604 in 2007 to €100,719 in 2024.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
See how customers, suppliers and banks see your own company and what to improve first.
If something looks wrong or is missing, please tell us.